Janney Montgomery Scott Starts Recro Pharma (REPH) at Buy
Tweet
Share
E-mailGet Alerts REPH Hot Sheet
Price: $2.09 --0%
Rating Summary:
10 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 60
Rating Summary:
10 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 60
Join SI Premium – FREE
Janney Montgomery Scott initiated coverage on Recro Pharma (NASDAQ: REPH) with a Buy rating and a price target of $21.00.
For an analyst ratings summary and ratings history on Recro Pharma click here. For more ratings news on Recro Pharma click here.
Shares of Recro Pharma closed at $9.15 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stifel Starts Arrowhead Pharma (ARWR) at Buy
- RBC Capital Starts Denison Mines (DNN) at Outperform
- Scotiabank Starts Telesat Corporation (TSAT:CN) at Sector Perform
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Janney Montgomery ScottSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
